Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Status of transition care in inflammatory bowel disease in Spain. Different medical perspectives.
Sánchez Sánchez C, Tolín Hernani MDM, Álvarez Calatayud G, Miranda Cid MDC, Navas López VM, Marín Jiménez I, Menchen LA, García Fernández P, Merino Sánchez-Cañete A. Sánchez Sánchez C, et al. Among authors: marin jimenez i. Rev Esp Enferm Dig. 2019 Nov;111(11):833-838. doi: 10.17235/reed.2019.6310/2019. Rev Esp Enferm Dig. 2019. PMID: 31566409 Free article.
Budesonide for ulcerative colitis.
Marín-Jiménez I, Peña AS. Marín-Jiménez I, et al. Rev Esp Enferm Dig. 2006 May;98(5):362-73. doi: 10.4321/s1130-01082006000500007. Rev Esp Enferm Dig. 2006. PMID: 16944997 Free article. Review. English, Spanish.
Refeeding syndrome in a patient with Crohn's disease.
Hernando A, Bretón I, Marín-Jimenez I, Menchén L. Hernando A, et al. Among authors: marin jimenez i. J Clin Gastroenterol. 2008 Apr;42(4):430-1. doi: 10.1097/01.mcg.0000247989.04463.54. J Clin Gastroenterol. 2008. PMID: 18277892 No abstract available.
[The placebo effect in inflammatory bowel disease].
Marín-Jiménez I. Marín-Jiménez I. Gastroenterol Hepatol. 2009 Oct;32 Suppl 2:44-9. doi: 10.1016/S0210-5705(09)72605-6. Gastroenterol Hepatol. 2009. PMID: 19900628 Spanish.
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.
Fortea-Ormaechea JI, González-Lama Y, Casis B, Chaparro M, López Serrano P, Van Domselaar M, Bermejo F, Pajares R, Ponferrada A, Vera MI, Martínez Montiel P, Gisbert JP, Pérez-Calle JL, López San Román A, Abreu L, Menchén LA, Marín-Jiménez I. Fortea-Ormaechea JI, et al. Among authors: marin jimenez i. Gastroenterol Hepatol. 2011 Aug-Sep;34(7):443-8. doi: 10.1016/j.gastrohep.2011.04.001. Epub 2011 Jul 2. Gastroenterol Hepatol. 2011. PMID: 21724297
Endogenous cannabinoid system regulates intestinal barrier function in vivo through cannabinoid type 1 receptor activation.
Zoppi S, Madrigal JL, Pérez-Nievas BG, Marín-Jiménez I, Caso JR, Alou L, García-Bueno B, Colón A, Manzanares J, Gómez-Lus ML, Menchén L, Leza JC. Zoppi S, et al. Among authors: marin jimenez i. Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G565-71. doi: 10.1152/ajpgi.00158.2011. Epub 2011 Dec 1. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 22135307 Free article.
[Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I, García Sánchez V, Gisbert JP, Lázaro Pérez Calle J, Luján M, Gordillo Ábalos J, Tabernero S, Juliá B, Romero C, Cea-Calvo L, García-Vicuña R, Vanaclocha F. Marín-Jiménez I, et al. Gastroenterol Hepatol. 2014 Nov;37(9):495-502. doi: 10.1016/j.gastrohep.2014.02.010. Epub 2014 Apr 8. Gastroenterol Hepatol. 2014. PMID: 24717523 Spanish.
136 results